Curcumin: A novel nutritionally derived ligand of the vitamin D receptor with implications for colon cancer chemoprevention

Leonid Bartik, G. Kerr Whitfield, Magdalena Kaczmarska, Christine L. Lowmiller, Eric W. Moffet, Julie K. Furmick, Zachary Hernandez, Carol A. Haussler, Mark R. Haussler, Peter Jurutka

Research output: Contribution to journalArticle

84 Citations (Scopus)

Abstract

The nuclear vitamin D receptor (VDR) mediates the actions of 1,25-dihydroxyvitamin D3 (1,25D) to regulate gene transcription. Recently, the secondary bile acid, lithocholate (LCA), was recognized as a novel VDR ligand. Using reporter gene and mammalian two-hybrid systems, immunoblotting, competitive ligand displacement and quantitative real-time PCR, we identified curcumin (CM), a turmeric-derived bioactive polyphenol, as a likely additional novel ligand for VDR. CM (10-5 M) activated transcription of a luciferase plasmid containing the distal vitamin D responsive element (VDRE) from the human CYP3A4 gene at levels comparable to 1,25D (10-8 M) in transfected human colon cancer cells (Caco-2). While CM also activated transcription via a retinoid X receptor (RXR) responsive element, activation of the glucocorticoid receptor (GR) by CM was negligible. Competition binding assays with radiolabeled 1,25D confirmed that CM binds directly to VDR. In mammalian two-hybrid assays employing transfected Caco-2 cells, CM (10-5 M) increased the ability of VDR to recruit its heterodimeric partner, RXR, and steroid receptor coactivator-1 (SRC-1). Real-time PCR studies revealed that CM-bound VDR can activate VDR target genes CYP3A4, CYP24, p21 and TRPV6 in Caco-2 cells. Numerous studies have shown chemoprotection by CM against intestinal cancers via a variety of mechanisms. Small intestine and colon are important VDR-expressing tissues where 1,25D has known anticancer properties that may, in part, be elicited by activation of CYP-mediated xenobiotic detoxification and/or up-regulation of the tumor suppressor p21. Our results suggest the novel hypothesis that nutritionally-derived CM facilitates chemoprevention via direct binding to, and activation of, VDR.

Original languageEnglish (US)
Pages (from-to)1153-1161
Number of pages9
JournalJournal of Nutritional Biochemistry
Volume21
Issue number12
DOIs
StatePublished - Dec 2010

Fingerprint

Calcitriol Receptors
Curcumin
Chemoprevention
Colonic Neoplasms
Ligands
Calcitriol
Caco-2 Cells
Transcription
Genes
Retinoid X Receptors
Cytochrome P-450 CYP3A
Chemical activation
Real-Time Polymerase Chain Reaction
Assays
Nuclear Receptor Coactivator 1
Lithocholic Acid
Intestinal Neoplasms
Curcuma
Detoxification
Two-Hybrid System Techniques

Keywords

  • Anticancer diet
  • Cancer prevention
  • Curcumin
  • Retinoid X receptor
  • Turmeric
  • Vitamin D receptor

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Molecular Biology
  • Endocrinology, Diabetes and Metabolism
  • Nutrition and Dietetics

Cite this

Curcumin : A novel nutritionally derived ligand of the vitamin D receptor with implications for colon cancer chemoprevention. / Bartik, Leonid; Whitfield, G. Kerr; Kaczmarska, Magdalena; Lowmiller, Christine L.; Moffet, Eric W.; Furmick, Julie K.; Hernandez, Zachary; Haussler, Carol A.; Haussler, Mark R.; Jurutka, Peter.

In: Journal of Nutritional Biochemistry, Vol. 21, No. 12, 12.2010, p. 1153-1161.

Research output: Contribution to journalArticle

Bartik, L, Whitfield, GK, Kaczmarska, M, Lowmiller, CL, Moffet, EW, Furmick, JK, Hernandez, Z, Haussler, CA, Haussler, MR & Jurutka, P 2010, 'Curcumin: A novel nutritionally derived ligand of the vitamin D receptor with implications for colon cancer chemoprevention', Journal of Nutritional Biochemistry, vol. 21, no. 12, pp. 1153-1161. https://doi.org/10.1016/j.jnutbio.2009.09.012
Bartik, Leonid ; Whitfield, G. Kerr ; Kaczmarska, Magdalena ; Lowmiller, Christine L. ; Moffet, Eric W. ; Furmick, Julie K. ; Hernandez, Zachary ; Haussler, Carol A. ; Haussler, Mark R. ; Jurutka, Peter. / Curcumin : A novel nutritionally derived ligand of the vitamin D receptor with implications for colon cancer chemoprevention. In: Journal of Nutritional Biochemistry. 2010 ; Vol. 21, No. 12. pp. 1153-1161.
@article{24684f30232044d0b09e6ecc4a0969ec,
title = "Curcumin: A novel nutritionally derived ligand of the vitamin D receptor with implications for colon cancer chemoprevention",
abstract = "The nuclear vitamin D receptor (VDR) mediates the actions of 1,25-dihydroxyvitamin D3 (1,25D) to regulate gene transcription. Recently, the secondary bile acid, lithocholate (LCA), was recognized as a novel VDR ligand. Using reporter gene and mammalian two-hybrid systems, immunoblotting, competitive ligand displacement and quantitative real-time PCR, we identified curcumin (CM), a turmeric-derived bioactive polyphenol, as a likely additional novel ligand for VDR. CM (10-5 M) activated transcription of a luciferase plasmid containing the distal vitamin D responsive element (VDRE) from the human CYP3A4 gene at levels comparable to 1,25D (10-8 M) in transfected human colon cancer cells (Caco-2). While CM also activated transcription via a retinoid X receptor (RXR) responsive element, activation of the glucocorticoid receptor (GR) by CM was negligible. Competition binding assays with radiolabeled 1,25D confirmed that CM binds directly to VDR. In mammalian two-hybrid assays employing transfected Caco-2 cells, CM (10-5 M) increased the ability of VDR to recruit its heterodimeric partner, RXR, and steroid receptor coactivator-1 (SRC-1). Real-time PCR studies revealed that CM-bound VDR can activate VDR target genes CYP3A4, CYP24, p21 and TRPV6 in Caco-2 cells. Numerous studies have shown chemoprotection by CM against intestinal cancers via a variety of mechanisms. Small intestine and colon are important VDR-expressing tissues where 1,25D has known anticancer properties that may, in part, be elicited by activation of CYP-mediated xenobiotic detoxification and/or up-regulation of the tumor suppressor p21. Our results suggest the novel hypothesis that nutritionally-derived CM facilitates chemoprevention via direct binding to, and activation of, VDR.",
keywords = "Anticancer diet, Cancer prevention, Curcumin, Retinoid X receptor, Turmeric, Vitamin D receptor",
author = "Leonid Bartik and Whitfield, {G. Kerr} and Magdalena Kaczmarska and Lowmiller, {Christine L.} and Moffet, {Eric W.} and Furmick, {Julie K.} and Zachary Hernandez and Haussler, {Carol A.} and Haussler, {Mark R.} and Peter Jurutka",
year = "2010",
month = "12",
doi = "10.1016/j.jnutbio.2009.09.012",
language = "English (US)",
volume = "21",
pages = "1153--1161",
journal = "Journal of Nutritional Biochemistry",
issn = "0955-2863",
publisher = "Elsevier Inc.",
number = "12",

}

TY - JOUR

T1 - Curcumin

T2 - A novel nutritionally derived ligand of the vitamin D receptor with implications for colon cancer chemoprevention

AU - Bartik, Leonid

AU - Whitfield, G. Kerr

AU - Kaczmarska, Magdalena

AU - Lowmiller, Christine L.

AU - Moffet, Eric W.

AU - Furmick, Julie K.

AU - Hernandez, Zachary

AU - Haussler, Carol A.

AU - Haussler, Mark R.

AU - Jurutka, Peter

PY - 2010/12

Y1 - 2010/12

N2 - The nuclear vitamin D receptor (VDR) mediates the actions of 1,25-dihydroxyvitamin D3 (1,25D) to regulate gene transcription. Recently, the secondary bile acid, lithocholate (LCA), was recognized as a novel VDR ligand. Using reporter gene and mammalian two-hybrid systems, immunoblotting, competitive ligand displacement and quantitative real-time PCR, we identified curcumin (CM), a turmeric-derived bioactive polyphenol, as a likely additional novel ligand for VDR. CM (10-5 M) activated transcription of a luciferase plasmid containing the distal vitamin D responsive element (VDRE) from the human CYP3A4 gene at levels comparable to 1,25D (10-8 M) in transfected human colon cancer cells (Caco-2). While CM also activated transcription via a retinoid X receptor (RXR) responsive element, activation of the glucocorticoid receptor (GR) by CM was negligible. Competition binding assays with radiolabeled 1,25D confirmed that CM binds directly to VDR. In mammalian two-hybrid assays employing transfected Caco-2 cells, CM (10-5 M) increased the ability of VDR to recruit its heterodimeric partner, RXR, and steroid receptor coactivator-1 (SRC-1). Real-time PCR studies revealed that CM-bound VDR can activate VDR target genes CYP3A4, CYP24, p21 and TRPV6 in Caco-2 cells. Numerous studies have shown chemoprotection by CM against intestinal cancers via a variety of mechanisms. Small intestine and colon are important VDR-expressing tissues where 1,25D has known anticancer properties that may, in part, be elicited by activation of CYP-mediated xenobiotic detoxification and/or up-regulation of the tumor suppressor p21. Our results suggest the novel hypothesis that nutritionally-derived CM facilitates chemoprevention via direct binding to, and activation of, VDR.

AB - The nuclear vitamin D receptor (VDR) mediates the actions of 1,25-dihydroxyvitamin D3 (1,25D) to regulate gene transcription. Recently, the secondary bile acid, lithocholate (LCA), was recognized as a novel VDR ligand. Using reporter gene and mammalian two-hybrid systems, immunoblotting, competitive ligand displacement and quantitative real-time PCR, we identified curcumin (CM), a turmeric-derived bioactive polyphenol, as a likely additional novel ligand for VDR. CM (10-5 M) activated transcription of a luciferase plasmid containing the distal vitamin D responsive element (VDRE) from the human CYP3A4 gene at levels comparable to 1,25D (10-8 M) in transfected human colon cancer cells (Caco-2). While CM also activated transcription via a retinoid X receptor (RXR) responsive element, activation of the glucocorticoid receptor (GR) by CM was negligible. Competition binding assays with radiolabeled 1,25D confirmed that CM binds directly to VDR. In mammalian two-hybrid assays employing transfected Caco-2 cells, CM (10-5 M) increased the ability of VDR to recruit its heterodimeric partner, RXR, and steroid receptor coactivator-1 (SRC-1). Real-time PCR studies revealed that CM-bound VDR can activate VDR target genes CYP3A4, CYP24, p21 and TRPV6 in Caco-2 cells. Numerous studies have shown chemoprotection by CM against intestinal cancers via a variety of mechanisms. Small intestine and colon are important VDR-expressing tissues where 1,25D has known anticancer properties that may, in part, be elicited by activation of CYP-mediated xenobiotic detoxification and/or up-regulation of the tumor suppressor p21. Our results suggest the novel hypothesis that nutritionally-derived CM facilitates chemoprevention via direct binding to, and activation of, VDR.

KW - Anticancer diet

KW - Cancer prevention

KW - Curcumin

KW - Retinoid X receptor

KW - Turmeric

KW - Vitamin D receptor

UR - http://www.scopus.com/inward/record.url?scp=78249260652&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78249260652&partnerID=8YFLogxK

U2 - 10.1016/j.jnutbio.2009.09.012

DO - 10.1016/j.jnutbio.2009.09.012

M3 - Article

C2 - 20153625

AN - SCOPUS:78249260652

VL - 21

SP - 1153

EP - 1161

JO - Journal of Nutritional Biochemistry

JF - Journal of Nutritional Biochemistry

SN - 0955-2863

IS - 12

ER -